112 related articles for article (PubMed ID: 8955058)
1. The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: analysis of second site revertants of a mutant MuLV lacking expression of this protein.
Portis JL; Fujisawa R; Mcatee FJ
Virology; 1996 Dec; 226(2):384-92. PubMed ID: 8955058
[TBL] [Abstract][Full Text] [Related]
2. Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.
Portis JL; Spangrude GJ; McAtee FJ
J Virol; 1994 Jun; 68(6):3879-87. PubMed ID: 8189525
[TBL] [Abstract][Full Text] [Related]
3. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
[TBL] [Abstract][Full Text] [Related]
4. Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release.
Low A; Datta S; Kuznetsov Y; Jahid S; Kothari N; McPherson A; Fan H
J Virol; 2007 Apr; 81(8):3685-92. PubMed ID: 17267509
[TBL] [Abstract][Full Text] [Related]
5. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses.
Corbin A; Prats AC; Darlix JL; Sitbon M
J Virol; 1994 Jun; 68(6):3857-67. PubMed ID: 8189523
[TBL] [Abstract][Full Text] [Related]
6. Reexamination of amphotropic murine leukemia virus neurovirulence: neural stem cell-mediated microglial infection fails to induce acute neurodegeneration.
Traister RS; Lynch WP
Virology; 2002 Feb; 293(2):262-72. PubMed ID: 11886246
[TBL] [Abstract][Full Text] [Related]
7. Unique sequence and lesional tropism of a new variant of neuropathogenic friend murine leukemia virus.
Takase-Yoden S; Watanabe R
Virology; 1997 Jul; 233(2):411-22. PubMed ID: 9217064
[TBL] [Abstract][Full Text] [Related]
8. The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag.
Fujisawa R; McAtee FJ; Wehrly K; Portis JL
J Virol; 1998 Jul; 72(7):5619-25. PubMed ID: 9621020
[TBL] [Abstract][Full Text] [Related]
9. Mapping of a neurovirulence determinant within the envelope protein of a polytropic murine retrovirus: induction of central nervous system disease by low levels of virus.
Poulsen DJ; Robertson SJ; Favara CA; Portis JL; Chesebro BW
Virology; 1998 Sep; 248(2):199-207. PubMed ID: 9721229
[TBL] [Abstract][Full Text] [Related]
10. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
Bishop KN; Bock M; Towers G; Stoye JP
J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
[TBL] [Abstract][Full Text] [Related]
11. Increased neurovirulence of polytropic mouse retroviruses delivered by inoculation of brain with infected neural stem cells.
Poulsen DJ; Favara C; Snyder EY; Portis J; Chesebro B
Virology; 1999 Oct; 263(1):23-9. PubMed ID: 10544079
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of HIV-1 and MuLV Gag.
Ott DE; Coren LV; Chertova EN; Gagliardi TD; Schubert U
Virology; 2000 Dec; 278(1):111-21. PubMed ID: 11112487
[TBL] [Abstract][Full Text] [Related]
13. The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag.
Nitta T; Tam R; Kim JW; Fan H
mBio; 2011; 2(1):e00341-10. PubMed ID: 21343359
[TBL] [Abstract][Full Text] [Related]
14. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
15. Second-site mutations encoding residues 34 and 78 of the major capsid protein (VP5) of herpes simplex virus type 1 are important for overcoming a blocked maturation cleavage site of the capsid scaffold proteins.
Warner SC; Desai P; Person S
Virology; 2000 Dec; 278(1):217-26. PubMed ID: 11112496
[TBL] [Abstract][Full Text] [Related]
16. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
17. Molecular and pathogenic characterization of the RFB osteoma virus: lack of oncogene and induction of osteoma, osteopetrosis, and lymphoma.
Gimbel W; Schmidt J; Brack-Werner R; Luz A; Strauss PG; Erfle V; Werner T
Virology; 1996 Oct; 224(2):533-8. PubMed ID: 8874513
[TBL] [Abstract][Full Text] [Related]
18. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
[TBL] [Abstract][Full Text] [Related]
19. Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses.
Crabtree MB; Kinney RM; Miller BR
Arch Virol; 2005 Apr; 150(4):771-86. PubMed ID: 15592895
[TBL] [Abstract][Full Text] [Related]
20. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
